Us Bancorp \De\ Fate Therapeutics Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 588 shares of FATE stock, worth $976. This represents 0.0% of its overall portfolio holdings.

Number of Shares

588

Previous 1,575 62.67%

Holding current value

$976

Previous $5,000 60.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$3.12 - $5.57 $3,079 - $5,497	-987 Reduced 62.67%	588 $2,000
Q2 2024 Aug 06, 2024	BUY	$3.26 - $7.08 $5,134 - $11,151	1,575 New	1,575 $5,000
Q4 2023 Feb 09, 2024	BUY	$1.65 - $3.94 $9,216 - $22,008	5,586 Added 232.27%	7,991 $29,000
Q3 2023 Nov 03, 2023	SELL	$2.02 - $5.04 $3,882 - $9,686	-1,922 Reduced 44.42%	2,405 $5,000
Q2 2023 Aug 09, 2023	BUY	$4.76 - $6.59 $9,929 - $13,746	2,086 Added 93.08%	4,327 $20,000
Q1 2023 May 09, 2023	BUY	$4.24 - $11.12 $3,964 - $10,397	935 Added 71.59%	2,241 $12,000
Q4 2022 Feb 13, 2023	SELL	$9.86 - $23.83 $122,500 - $296,063	-12,424 Reduced 90.49%	1,306 $13,000
Q3 2022 Oct 27, 2022	BUY	$21.04 - $36.06 $281,136 - $481,833	13,362 Added 3630.98%	13,730 $307,000
Q2 2022 Aug 01, 2022	BUY	$17.78 - $42.39 $1,209 - $2,882	68 Added 22.67%	368 $9,000
Q1 2022 May 11, 2022	SELL	$29.67 - $60.28 $5,340 - $10,850	-180 Reduced 37.5%	300 $11,000
Q4 2021 Feb 11, 2022	SELL	$47.84 - $64.34 $10,189 - $13,704	-213 Reduced 30.74%	480 $28,000
Q3 2021 Nov 10, 2021	SELL	$59.27 - $95.73 $5,749 - $9,285	-97 Reduced 12.28%	693 $41,000
Q2 2021 Aug 05, 2021	BUY	$67.25 - $92.52 $18,023 - $24,795	268 Added 51.34%	790 $68,000
Q1 2021 Apr 28, 2021	BUY	$72.16 - $117.4 $29,369 - $47,781	407 Added 353.91%	522 $43,000
Q4 2020 Feb 04, 2021	BUY	$38.09 - $100.95 $3,732 - $9,893	98 Added 576.47%	115 $11,000
Q2 2020 Aug 07, 2020	BUY	$20.21 - $35.23 $343 - $598	17 New	17 $1,000
Q4 2018 Feb 13, 2019	SELL	$11.48 - $16.98 $10,584 - $15,655	-922 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$8.75 - $16.29 $542 - $1,009	62 Added 7.21%	922 $15,000
Q2 2018 Aug 08, 2018	BUY	$9.16 - $13.48 $7,877 - $11,592	860 New	860 $10,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $161M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account